During the past decade, Institut für Diabetesforschung GmbH Münster conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 7 clinical trials were completed, i.e. on average, 63.6% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 5 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institut für Diabetesforschung GmbH Münster" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator, "Kinetic Concepts, Inc." with 1 trials as a collaborator and "Smith & Nephew Wound Management Inc" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Institut für Diabetesforschung GmbH Münster" are "Type 1 Diabetes Mellitus" (3 trials), "Type 2 Diabetes" (3 trials), "Obesity" (2 trials), "Type 2 Diabetes Mellitus" (2 trials) and "Diabetes Mellitus, Type 1" (1 trials). Many other conditions were trialed in "Institut für Diabetesforschung GmbH Münster" in a lesser frequency.

Most popular intervention types in "Institut für Diabetesforschung GmbH Münster" are "Drug" (12 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Tirzepatide" (5 trials), "Dulaglutide" (2 trials), "Insulin Degludec" (2 trials) and "LY3209590" (2 trials). Other intervention names were less common.

The vast majority of trials in "Institut für Diabetesforschung GmbH Münster" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Institut für Diabetesforschung GmbH Münster". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Institut für Diabetesforschung GmbH Münster, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Institut für Diabetesforschung GmbH Münster, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".